Skip to main content

Table 7 Effectiveness of the EMPOWER-PAR intervention in achieving the primary and secondary outcome measures at 1-year follow-up

From: Effectiveness of the EMPOWER-PAR Intervention in Improving Clinical Outcomes of Type 2 Diabetes Mellitus in Primary Care: A Pragmatic Cluster Randomised Controlled Trial

Clinical outcome measures Intervention Control Model summaryb
Baseline % Follow-up % Changea % Baseline % Follow-up % Changea % Odds Ratio (95% CI)c P valued
Primary outcome
 HbA1c <6.5%/ 15.3 18.3 3.0 17.0 12.9 −4.1 2.16 (1.34, 3.50) 0.002
<48 mmol/mol
Secondary outcomes
 BP ≤ 130/80 mmHg 24.8 24.4 −0.4 25.9 21.1 −4.8 1.27 (0.91, 1.78) 0.16
 BMI < 22.9 kg/m2 15.7 15.4 −0.3 12.7 11.9 −0.8 1.27 (0.70, 2.31) 0.44
 WC <90 cm (M) 11.3 8.8 −2.5 12.5 9.6 −2.9 1.01 (0.53, 1.93) 0.97
<80 cm (F)
 TC ≤ 4.5 mmol/L 26.8 29.6 2.8 26.9 29.2 2.3 1.03 (0.74, 1.43) 0.86
 TG ≤ 1.7 mmol/L 45.4 46.9 1.5 52.8 52.8 0 0.87 (0.65, 1.18) 0.38
 LDL-c ≤ 2.6 mmol/L 31.9 32.5 0.6 31.2 29.8 −1.4 1.15 (0.83, 1.60) 0.41
 HDL-c ≥ 1.1 mmol/L 60.9 62.2 1.3 66.7 69.0 2.3 0.79 (0.56, 1.12) 0.19
  1. Intention to treat analysis was performed for primary and secondary outcome measures
  2. aChange in the proportion of patients achieving clinical outcomes: Follow-up - Baseline
  3. bEstimates were derived using GEE. Results were adjusted for baseline values and cluster effect
  4. cOdds for achieving clinical outcome measures in the intervention group compared with control group
  5. dSignificance of intervention term in model
  6. Bold data represents statistically significant results i.e P value < 0.05